This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
It also creates a visual draft or wireframe for you, 100 7504 0 7504 00 6126 0 --:--:-- 0:00:01 --:--:-- 6130 suggesting headlines, body copy, calls to action, and even recommending visuals or ideal placements. Smarter Tagging with AI Metadata tagging just got an upgrade.
Mansard House Church Road Little Bookham Leatherhead Surrey KT23 3JG E: editorial@pharmatimes.com E: subscriptions@pharmatimes.com T: +44 (0)20 7240 6999 F: +44 (0)20 7240 4479 Get the latest pharma news delivered to your inbox A valid email address is required.
Mansard House Church Road Little Bookham Leatherhead Surrey KT23 3JG E: editorial@pharmatimes.com E: subscriptions@pharmatimes.com T: +44 (0)20 7240 6999 F: +44 (0)20 7240 4479 Get the latest pharma news delivered to your inbox A valid email address is required.
Mansard House Church Road Little Bookham Leatherhead Surrey KT23 3JG E: editorial@pharmatimes.com E: subscriptions@pharmatimes.com T: +44 (0)20 7240 6999 F: +44 (0)20 7240 4479 Get the latest pharma news delivered to your inbox A valid email address is required. This field is required.
This category is designed to challenge digital and clinical individuals on their understanding of the importance decentralised solutions play in Clinical Research, from study design and development of relevant and appropriate solutions to execution. Introducing the Decentralised Solutions Individual of the Year category.
Mansard House Church Road Little Bookham Leatherhead Surrey KT23 3JG E: editorial@pharmatimes.com E: subscriptions@pharmatimes.com T: +44 (0)20 7240 6999 F: +44 (0)20 7240 4479 Get the latest pharma news delivered to your inbox A valid email address is required. This field is required.
Tags Related posts Migraine takes the spotlight at European Parliament Jun 12, 2025 Bimekizumab shows lasting efficacy at EULAR 2025 Jun 11, 2025 Argenx presents new efgartigimod data at EULAR 2025 Jun 11, 2025 Tagomics secures £860k grant for colorectal cancer test Jun 10, 2025 News alerts This field is required.
Tags Related posts Levicept presents new LEVI-04 data at EULAR Jun 12, 2025 Migraine takes the spotlight at European Parliament Jun 12, 2025 Bimekizumab shows lasting efficacy at EULAR 2025 Jun 11, 2025 Argenx presents new efgartigimod data at EULAR 2025 Jun 11, 2025 News alerts This field is required.
Central to the programme is Kidney Essentials, a multilingual digital resource co-created with patients and clinicians. It aligns with NHS England’s goals to shift care into communities, promote prevention and use digital services to ease pressure on frontline care.
Mansard House Church Road Little Bookham Leatherhead Surrey KT23 3JG E: editorial@pharmatimes.com E: subscriptions@pharmatimes.com T: +44 (0)20 7240 6999 F: +44 (0)20 7240 4479 Get the latest pharma news delivered to your inbox A valid email address is required.
The partnership builds on Proximie’s recent collaborations with Olympus Corporation and Distalmotion, reinforcing its role in advancing digital surge. The five-year survival rate for primary liver cancer remains below 18 percent, highlighting the urgent need for innovative treatment approaches.
Mansard House Church Road Little Bookham Leatherhead Surrey KT23 3JG E: editorial@pharmatimes.com E: subscriptions@pharmatimes.com T: +44 (0)20 7240 6999 F: +44 (0)20 7240 4479 Get the latest pharma news delivered to your inbox A valid email address is required.
Mansard House Church Road Little Bookham Leatherhead Surrey KT23 3JG E: editorial@pharmatimes.com E: subscriptions@pharmatimes.com T: +44 (0)20 7240 6999 F: +44 (0)20 7240 4479 Get the latest pharma news delivered to your inbox A valid email address is required.
Tags Related posts Bimekizumab shows lasting efficacy at EULAR 2025 Jun 11, 2025 Argenx presents new efgartigimod data at EULAR 2025 Jun 11, 2025 Tagomics secures £860k grant for colorectal cancer test Jun 10, 2025 PharmaTimes Clinical Researcher of the Year – The Americas Jun 9, 2025 News alerts This field is required.
Tags Related posts Investigational treatment shows promise for aggressive multiple myeloma Jun 16, 2025 Levicept presents new LEVI-04 data at EULAR Jun 12, 2025 Migraine takes the spotlight at European Parliament Jun 12, 2025 Bimekizumab shows lasting efficacy at EULAR 2025 Jun 11, 2025 News alerts This field is required.
Each DA scale scores from 0 to 100. PA ratings, like DA, run from 0 to 100, with higher scores indicating a better likelihood of having a higher ranking in the SERPs and vice versa. HIPAA-covered entities include any digital business firm or institution that provides treatment, payment, or operations in the healthcare industry.
Each DA scale scores from 0 to 100. PA ratings, like DA, run from 0 to 100, with higher scores indicating a better likelihood of having a higher ranking in the SERPs and vice versa. HIPAA-covered entities include any digital business firm or institution that provides treatment, payment, or operations in the healthcare industry.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content